Quarterly report pursuant to Section 13 or 15(d)

Acquisitions - Schedule of Contingent Consideration Rollforward (Details)

v3.19.3
Acquisitions - Schedule of Contingent Consideration Rollforward (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
May 31, 2019
Apr. 30, 2019
Jun. 30, 2019
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Deferred Cash and Stock Obligations              
Deferred Cash and Stock Obligations Beginning Balance         $ 52,142 $ 47,016 $ 47,016
Additions, net of fair value discount         9,653   36,313
Cash payments         (20,914)   (29,600)
Settlements through common stock issued         (14,846)    
Accretion expense         1,302   1,970
Change in fair value         0   0
Indemnification claims and other adjustments         130   (3,557)
Deferred Cash and Stock Obligations Ending Balance $ 27,467       27,467   52,142
Contingent Consideration              
Contingent Consideration Beginning Balance         6,000 414 414
Additions, net of fair value discount         6,700   7,000
Cash payments         (5,963)   (247)
Settlements through common stock issued         0    
Accretion expense         58   0
Change in fair value         (37)   (1,167)
Indemnification claims and other adjustments         0   0
Contingent Consideration Ending Balance 6,758       6,758   6,000
Total              
Total Beginning Balance         58,142 47,430 47,430
Additions, net of fair value discount         16,353   43,313
Cash payments         (26,877)   (29,847)
Settlements through common stock issued         (14,846) 0  
Accretion expense         1,360   1,970
Change in fair value         (37)   (1,167)
Indemnification claims and other adjustments         130   (3,557)
Total Ending Liability $ 34,225       $ 34,225   $ 58,142
NovelPay and ClickPay              
Business Acquisition [Line Items]              
Shares issued for 2018 acquisitions (in shares)   154,281          
LeaseLabs              
Contingent Consideration              
Cash payments     $ (6,000) $ (6,000)      
Contingent Consideration Ending Balance           $ 7,000  
Business Acquisition [Line Items]              
Issuance of common stock in connection with our acquisitions (in shares) 80,012